MR编号 | NL/H/4927/001 |
---|
药品名称 | Pemetrexed Sandoz 25 mg/ml, concentrate for solution for infusion |
---|
活性成分 | - Pemetrexed disodium 25.0 mg/ml
|
---|
剂型 | Concentrate for solution for infusion |
---|
上市许可持有人 | Sandoz B.V.
Veluwezoom 22
1327 AH Almere
The Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) Pemetrexed Sandoz 25 mg/ml, concentraat voor oplossing voor infusie |
---|
互认成员国 - 产品名称 | - Denmark (DK)
Pemtrexed "Hexal" - Belgium (BE)
Pemetrexed Sandoz 25 mg/ml concentraat voor oplossing voor infusie - Iceland (IS)
Pemetrexed Hexal 25 mg/ml Innrennslisþykkni, lausn - Austria (AT)
Pemetrexed Sandoz 25 mg/ml – Konzentrat zur Herstellung einer Infusionslösung - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
Pemetrexed Hexal - Finland (FI)
- Poland (PL)
Pemetrexed Sandoz - Lithuania (LT)
Pemetrexed Ebewe 25 mg/ml koncentratas infuziniam tirpalui - Bulgaria (BG)
Pemetrexed Sandoz - Romania (RO)
- Slovenia (SI)
- Cyprus (CY)
Pemetrexed Sandoz πυκνό διάλυμα για παρασκευή διαλύματος προς έγχυση 25mg/ml - Malta (MT)
- Croatia (HR)
- United Kingdom (Northern Ireland) (XI)
|
---|
许可日期 | 2020/06/10 |
---|
最近更新日期 | 2025/01/16 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|